GSK Stock - Analyst consensus and sector backdrop on a quiet news day
19.06.2026 - 21:58:20 | ad-hoc-news.de
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 19:55 UTC. Details in the imprint.
GSK (GB0009252882) enters the end of the week without a new company-specific market announcement. Investors instead weigh the existing analyst consensus and how the stock is positioned against large-cap pharmaceutical peers, based on current market data.
Background and market data on GSK stock
Key figures, historical prices and further corporate information help investors frame GSK’s current valuation within the global pharma sector.
What current market data shows
GSK stock is listed on the London Stock Exchange under the ticker GSK and trades in British pounds, with a parallel listing on the New York Stock Exchange in US dollars for its ADRs, giving it broad international investor access. Financial Times markets data provide an overview of the main listings.
According to recent quote data for the London line, GSK shares last changed hands around GBX 1,925, placing the stock below its 52-week high near GBX 2,282 and above the 52-week low around GBX 1,315, highlighting a mid-range valuation band for the year. The FT summary page shows these trading ranges.
How GSK compares with peers
Within the large-cap pharmaceuticals universe, GSK competes with companies such as Pfizer, Sanofi and AstraZeneca, all of which have diversified portfolios and global scale, but different geographic and therapeutic exposures, which can influence valuation and earnings stability.
While recent sector performance has been mixed, defensive characteristics of big pharma names and recurring vaccine and specialty-medicine revenues continue to support interest from income-focused investors, especially where dividend policies are clearly communicated and underpinned by cash generation.
How GSK makes its money
GSK generates revenue primarily from prescription medicines, vaccines and consumer healthcare royalties, with key products including the shingles vaccine Shingrix and respiratory and HIV treatments, complemented by a pipeline of specialty drugs and vaccines under development.
Where the stock trades today
The shares of GSK (GB0009252882) trade on the London Stock Exchange at approximately GBX 1,925 as of 06/19/2026, 19:55 UTC.
Key facts on GSK stock
- Company: GSK plc
- ISIN: GB0009252882
- WKN: 940561
- Ticker: GSK
- Venue: London Stock Exchange
- Price (as of 06/19/2026, 19:55 UTC): 1,925.00 GBX
- Market cap: 79,000,000,000 GBP (as of 06/19/2026)
- Sector / Industry: Health Care / Pharmaceuticals & Biotechnology
- Index membership: FTSE 100
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
